Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Ingels

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|November 5, 2021
Myosteatosis as an independent risk factor for mortality after kidney allograft transplantation: a retrospective cohort studyAntoine Morel, Yaniss Ouamri, Florence Canouï-Poitrine, et al.
Cancers|August 12, 2022
Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder CancerElliott Diamant, Mathieu Roumiguié, Alexandre Ingels, et al.
Contrast Media & Molecular Imaging|November 4, 2017
Molecular Imaging to Predict Response to Targeted Therapies in Renal Cell CarcinomaIngrid Leguerney, Ludovic de Rochefort, Marie Poirier-Quinot, et al.
The Prostate|October 27, 2015
First off-time treatment prostate-specific antigen kinetics predicts survival in intermittent androgen deprivation for prostate cancerRafael Sanchez-Salas, Fabien Olivier, Dominique Prapotnich, et al.
Minerva Urology and Nephrology|May 24, 2022
Selecting the best candidates for non-surgical management of localized renal masses: the Occam's razorRiccardo Campi, Stijn Muselaers, Riccardo Bertolo, et al.
Minerva Urology and Nephrology|May 24, 2022
Finding novel prognostic factors in metastatic renal cell carcinoma: what does peripheral blood tell us?Laura Marandino, Riccardo Campi, Selçuk Erdem, et al.
Cancers|February 11, 2023
Genomic Prostate Score: A New Tool to Assess Prognosis and Optimize Radiation Therapy Volumes and ADT in Intermediate-Risk Prostate CancerYazid Belkacemi, Kamel Debbi, Gabriele Coraggio, et al.
British Journal of Cancer|November 11, 2018
The clinical role of the TME in solid cancerNicolas A Giraldo, Rafael Sanchez-Salas, J David Peske, et al.
European Urology Open Science|November 3, 2022
Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence?Michele Marchioni, Daniele Amparore, Laura Marandino, et al.
Advances in Radiation Oncology|July 6, 2023
Effect of Serelys Homme on the Incidence and Severity of Vasomotor Symptoms and Quality-of-Life Impairments in Patients Receiving Hormone Therapy and Radiation for Localized Prostate Cancer: Results of the ESCULAPE Phase 2 Prospective StudyYazid Belkacemi, Gabriele Coraggio, Anne Brunel, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Journal of Cachexia, Sarcopenia and Muscle|November 5, 2021
Myosteatosis as an independent risk factor for mortality after kidney allograft transplantation: a retrospective cohort studyAntoine Morel, Yaniss Ouamri, Florence Canouï-Poitrine, et al.
Cancers|August 12, 2022
Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder CancerElliott Diamant, Mathieu Roumiguié, Alexandre Ingels, et al.
Contrast Media & Molecular Imaging|November 4, 2017
Molecular Imaging to Predict Response to Targeted Therapies in Renal Cell CarcinomaIngrid Leguerney, Ludovic de Rochefort, Marie Poirier-Quinot, et al.
The Prostate|October 27, 2015
First off-time treatment prostate-specific antigen kinetics predicts survival in intermittent androgen deprivation for prostate cancerRafael Sanchez-Salas, Fabien Olivier, Dominique Prapotnich, et al.
Minerva Urology and Nephrology|May 24, 2022
Selecting the best candidates for non-surgical management of localized renal masses: the Occam's razorRiccardo Campi, Stijn Muselaers, Riccardo Bertolo, et al.
Minerva Urology and Nephrology|May 24, 2022
Finding novel prognostic factors in metastatic renal cell carcinoma: what does peripheral blood tell us?Laura Marandino, Riccardo Campi, Selçuk Erdem, et al.
Cancers|February 11, 2023
Genomic Prostate Score: A New Tool to Assess Prognosis and Optimize Radiation Therapy Volumes and ADT in Intermediate-Risk Prostate CancerYazid Belkacemi, Kamel Debbi, Gabriele Coraggio, et al.
British Journal of Cancer|November 11, 2018
The clinical role of the TME in solid cancerNicolas A Giraldo, Rafael Sanchez-Salas, J David Peske, et al.
European Urology Open Science|November 3, 2022
Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence?Michele Marchioni, Daniele Amparore, Laura Marandino, et al.
Advances in Radiation Oncology|July 6, 2023
Effect of Serelys Homme on the Incidence and Severity of Vasomotor Symptoms and Quality-of-Life Impairments in Patients Receiving Hormone Therapy and Radiation for Localized Prostate Cancer: Results of the ESCULAPE Phase 2 Prospective StudyYazid Belkacemi, Gabriele Coraggio, Anne Brunel, et al.
Pageof 9